We use cookies to improve your experience on our websites and to make visit statistics.
Galatek and MissionDx Announce Strategic Partnership to Advance Automated Molecular Diagnostics in North America
04.14 2026
Singapore, April 14, 2026 — Galatek, a Singapore-based technology company specializing in laboratory automation and advanced instrumentation, today announced the signing of a Commercial Collaboration Framework Agreement with MissionDx to co-develop and deploy automated molecular testing solutions, targeting the North American market.
This strategic collaboration brings together Galatek's strengths in automation engineering and integrated laboratory platforms with MissionDx's established commercial infrastructure, deep clinical market relationships, and proven track record in molecular diagnostics commercialization. Together, the two companies aim to accelerate the development and commercialization of next-generation diagnostic solutions that are faster, more scalable, and highly reliable.
Molecular testing plays a critical role in modern healthcare by enabling rapid and precise detection of genetic material across infectious disease, oncology, and genetic screening applications. Through this partnership, Galatek and MissionDx will work together to deliver solutions that streamline laboratory workflows while improving accessibility to high-quality diagnostics — with a shared ambition to displace legacy platforms that have failed to keep pace with modern laboratory demands. As a centerpiece of the collaboration, the companies will establish a joint Reference Laboratory in Holliston, Massachusetts, designed to serve as both a live demonstration of fully automated molecular workflows in a CLIA-certified clinical testing operation.
About Galatek Galatek is a Singapore-based technology company specializing in advanced automation, precision engineering, and integrated solutions across the life sciences and semiconductor sectors. With a strong focus on innovation and scalability, Galatek develops cutting-edge platforms that enhance operational efficiency and enable next-generation applications in high-growth industries.
About MissionDx Mission Diagnostics is a diagnostics commercialization company focused on high-growth laboratory testing markets including molecular/PCR, quantitative urinalysis, toxicology, and hematology controls. Built on the established infrastructure of Diamond Diagnostics and led by veterans of Abbott, Thermo Fisher Scientific, and Mindray, MissionDx combines deep market expertise and established distribution capabilities to bring innovative diagnostic solutions to laboratories across the United States.